Generate epidemiology evidence to support the maintenance of day-to-day signal/risk management of BMS assets in development and early post-approval.
Base: zł227,340 - zł275,484; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Competitive benefits, services and programs
Must-have
Nice-to-have
Not specified